Dylan Fortman, Hong Wang, Robert VanderWeele, Terry Evans, James G Herman, John Rhee, Vincent Reyes, Brian McLaughlin, Antoinette Wozniak, Ashwin Somasundaram, Tarek Mekhail, Mark A Socinski, Katja Schulze, Liza C Villaruz
{"title":"简要报告:曾接受 PD-1 导向疗法治疗的晚期非小细胞肺癌患者的 Atezolizumab II 期临床试验。","authors":"Dylan Fortman, Hong Wang, Robert VanderWeele, Terry Evans, James G Herman, John Rhee, Vincent Reyes, Brian McLaughlin, Antoinette Wozniak, Ashwin Somasundaram, Tarek Mekhail, Mark A Socinski, Katja Schulze, Liza C Villaruz","doi":"10.1016/j.cllc.2024.10.014","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":10490,"journal":{"name":"Clinical lung cancer","volume":" ","pages":""},"PeriodicalIF":3.3000,"publicationDate":"2024-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Brief Report: Phase II Clinical Trial of Atezolizumab in Advanced Nonsmall Cell Lung Cancer Patients Previously Treated With PD-1-Directed Therapy.\",\"authors\":\"Dylan Fortman, Hong Wang, Robert VanderWeele, Terry Evans, James G Herman, John Rhee, Vincent Reyes, Brian McLaughlin, Antoinette Wozniak, Ashwin Somasundaram, Tarek Mekhail, Mark A Socinski, Katja Schulze, Liza C Villaruz\",\"doi\":\"10.1016/j.cllc.2024.10.014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":10490,\"journal\":{\"name\":\"Clinical lung cancer\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":3.3000,\"publicationDate\":\"2024-10-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical lung cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.cllc.2024.10.014\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical lung cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.cllc.2024.10.014","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
期刊介绍:
Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.